Globus Medical (GMED) Earnings Expected to Grow: Should You Buy?

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Globus Medical, driven by higher revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - The upcoming earnings report is expected to show quarterly earnings of $0.74 per share, reflecting a +2.8% change year-over-year, with revenues projected at $628.32 million, up 3.6% from the previous year [3]. Estimate Revisions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating a stable outlook from analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that the Most Accurate Estimate for Globus Medical is higher than the consensus estimate, resulting in a positive Earnings ESP of +2.40%, indicating a bullish sentiment among analysts [10]. Historical Performance - Globus Medical has a strong track record, having beaten consensus EPS estimates in the last four quarters, including a +10.53% surprise in the most recent quarter [12][13]. Stock Ranking - The company currently holds a Zacks Rank of 3, suggesting a likelihood of beating the consensus EPS estimate [11]. Conclusion - Globus Medical is positioned as a compelling candidate for an earnings beat, but investors should consider additional factors beyond earnings expectations when making investment decisions [16].